Ligand Pharmaceuticals Inc <LGND.O>: Benchmark Raises Target Price to $335 from $275
LGND•Related News
CVR Partners updates financial calendar for second-quarter earnings release and investor call
UAN•
Pagaya closes USD 750 million auto ABS transaction RPM 2026-4
PGY•
Uber in $15 billion deal for Delivery Hero to create global takeout giant
UBER•
US retail sales rise marginally in June
SPY•
US June retail sales data
SPY•